Remove tag atrial-fibrillation
article thumbnail

Grand Rounds February 17, 2023: The Heartline Trial: A New Paradigm in Conducting Virtual Clinical Trials (C. Michael Gibson, MS, MD)

Rethinking Clinical Trials

The Heartline Trial is a randomized trial of up to 28,000 patients to test whether the new Apple watch (with built-in single lead EKG) can detect new onset atrial fibrillation in participants age 65 and older. Providers must now earn the trust of relatively informed and knowledgeable patients through a two-way conversation.

article thumbnail

Life Sciences 2022 Year in Review

XTalks

The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive. Currently, CSL Behring’s one-dose Hemophilia B gene therapy Hemgenix holds the title at $3.5 million for a single infusion.

article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

First-quarter 2021 operational growth was primarily driven by: BNT162b2, which contributed $3.5 billion in global revenues; Eliquis globally, up 25% operationally, led by growth in the U.S., and Japan; Xeljanz globally, up 18% operationally, primarily driven by: 16% growth in the U.S., in December 2019; and. Amy Rose 212.733.7410. Source link.